

Until the early 1990s, the wound healing industry was made up of a small number of products. Wet to dry dressings were the standard using simple cotton gauze. That all changed when our founder, Dr. Manoj K Jain, discovered how to preserve the collagen molecule and manufacture products. This molecule, when properly preserved, would create the foundation for our business and the entire advanced wound care industry.
In 1991, the FDA cleared for sale Kollagen™ products based on Dr. Jain’s collagen technology. With these products, healthcare professionals gained the ability to directly interact with the wound and take control of the healing process for the first time. After 10 years of extensive use, the Department of Health and Human Services listened to clinicians, recognized these benefits, and created an entirely new category of Medicare reimbursement codes for collagen. The new availability of insurance payments for collagen products would pave the way for other collagen products to be developed. Ultimately, it would take ten years after the release of our first Kollagen™ products for a competitor to receive FDA clearance for a collagen product. Now collagen is the standard for wound care, and Kollagen™ is the standard for collagen.












HBS is founded by Dr. Manoj K Jain in Kansas
HBS receives several research grants
Kollagen™ is developed- the world’s first collagen wound care dressings are cleared by the FDA
First collagen veterinary products are developed
Patent for collagen processing is issued
New headquarters established in Maryland
Special Medicare reimbursement codes are developed for collagen products, paving the way for the industry
First Taiwan joint venture is opened
A new line of collagen products are cleared by the FDA
Company is rebranded to Human BioSciences
Dr. Jain receives the Thomas Alva Edison patent award
Kollagen™ products are approved as lifesaving drugs in India
HBS opens a lab in Germany
Indian facility starts production
Multiple new products and systems under development in USA, India and Germany.
Breakthrough new manufacturing technology is developed in USA.
30 year anniversary of HBS
Flagship manufacturing facility is fully outfitted with new manufacturing technology
Introduced the first line of Veterinary Kollavet Products.
Dr. Rohan Jain is promoted to President of Human BioSciences. New OTC & secondary wound dressing product line is launched.
HBS is founded by Dr. Manoj K Jain in Kansas
HBS receives several research grants
Kollagen™ is developed- the world’s first collagen wound care dressings are cleared by the FDA
First collagen veterinary products are developed
Patent for collagen processing is issued
New headquarters established in Maryland
Special Medicare reimbursement codes are developed for collagen products, paving the way for the industry
First Taiwan joint venture is opened
A new line of collagen products are cleared by the FDA
Company is rebranded to Human BioSciences
Dr. Jain receives the Thomas Alva Edison patent award
Kollagen™ products are approved as lifesaving drugs in India
HBS opens a lab in Germany
Indian facility starts production
Multiple new products and systems under development in USA, India and Germany.
Breakthrough new manufacturing technology is developed in USA.
30 year anniversary of HBS
Flagship manufacturing facility is fully outfitted with new manufacturing technology
Introduced the first line of Veterinary Kollavet Products.
Dr. Rohan Jain is promoted to President of Human BioSciences. New OTC & secondary wound dressing product line is launched.
Introduced an e-commerce website (www.usehbs.com) & began selling OTC and Animal products on Amazon.
New joint venture / Global expansion in countries like Saudi Arabia and Kenya.
New manufacturing facility opened in West Virginia.
Join today and stay updated
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |

Mr. Vann oversees E-Commerce, Inventory, and Facilities, ensuring optimal product and supply management across medical, nutraceutical, and cosmetic lines.
With a dedication to accuracy and reliability, he brings a wealth of experience as an innovative project coordinator adept at managing diverse initiatives and streamlining processes.
He holds a Bachelor’s of Science Degree in Environmental Science and Technology from the University of Maryland and started his career at the Smithsonian Institution, spearheading green initiatives for the annual Folklife Festival with the Metropolitan Washington Council of Governments.
New headquarters established in Maryland
Patent for collagen processing is issued
First collagen veterinary products are developed
Kollagen™ is developed- the world’s first collagen wound care dressings are cleared by the FDA
HBS receives several research grants
HBS is founded by Manoj. K. Jain in Kansas.

Creative Director, Human BioSciences
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company.
Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international.
She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.

Mr. Slovick is responsible for all regulatory and quality affairs in the company.
Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years.
He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.

Vice President of Operations, Human BioSciences
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS.
He has served multiple positions within HBS since 2001, including Operations Manager.
With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.

General Counsel
Mr. Dickieson, as General Counsel, is involved with Human Biosciences’ efforts to expand internationally while aiding with growth and legal compliance in the U.S.
He has over 40 years of experience as a trial attorney with the U.S. Department of Justice and with Washington, D.C. law firms. His law degree is from the University of Michigan and he received a Bachelors Degree in Government from Cornell.

President, Human BioSciences
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development.
Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market.
Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.